• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by PACS Group Inc.

    11/24/25 5:29:28 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care
    Get the next $PACS alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001584147
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Pacs Group, Inc.
    SEC File Number
    001-42011
    Address of Issuer
    262 N. University Ave.
    Farmington
    UTAH
    84025
    Phone
    801-447-9829
    Name of Person for Whose Account the Securities are To Be Sold
    John Todd Mitchell
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Chief Legal Officer

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common Stock
    J.P. Morgan Securities LLC
    270 Park Avenue - 10th Floor
    New York � NY � 10017
    159556438779015661514411/24/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common Stock04/15/2024RSU VestingIssuerCheckbox not checked15955604/15/2024N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    Date of Notice
    11/24/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for John Todd Mitchell

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $PACS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $PACS

    DatePrice TargetRatingAnalyst
    12/17/2024$18.00Overweight → Neutral
    Analyst
    11/6/2024$40.00Overweight
    JP Morgan
    10/9/2024$50.00Buy
    UBS
    9/11/2024$45.00Buy
    Citigroup
    6/28/2024$35.00Outperform
    Macquarie
    More analyst ratings

    $PACS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Announces NYSE Listing Extension and Provides Select Preliminary Interim Operating Metrics

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), on September 10, 2025, announced that on September 9, 2025, the New York Stock Exchange ("NYSE") Listing Operations Committee agreed to provide the Company with an additional trading period through November 19, 2025, subject to its ongoing review of the Company. The additional trading period provides PACS additional time to complete the previously announced restatement of its financial statements for the three months ended March 31, 2024, and the three and six months ended June 30, 2024 and become current with its SEC filing obligations, which are required for the Company to regain compliance with the NYSE listing standards. "We have

    9/11/25 8:17:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    PACS Group downgraded by Analyst with a new price target

    Analyst downgraded PACS Group from Overweight to Neutral and set a new price target of $18.00

    12/17/24 8:16:05 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    JP Morgan resumed coverage on PACS Group with a new price target

    JP Morgan resumed coverage of PACS Group with a rating of Overweight and set a new price target of $40.00

    11/6/24 6:27:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    UBS initiated coverage on PACS Group with a new price target

    UBS initiated coverage of PACS Group with a rating of Buy and set a new price target of $50.00

    10/9/24 7:56:46 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    SEC Filings

    View All

    SEC Form DEF 14A filed by PACS Group Inc.

    DEF 14A - PACS Group, Inc. (0002001184) (Filer)

    11/25/25 4:03:34 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form 144 filed by PACS Group Inc.

    144 - PACS Group, Inc. (0002001184) (Subject)

    11/24/25 5:29:28 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form S-8 filed by PACS Group Inc.

    S-8 - PACS Group, Inc. (0002001184) (Filer)

    11/19/25 4:07:14 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dilsaver Evelyn S bought $499,997 worth of shares (16,724 units at $29.90), increasing direct ownership by 278% to 22,739 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:46:20 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Legal Officer & Sec. Mitchell John Todd sold $4,768,379 worth of shares (159,556 units at $29.89), decreasing direct ownership by 17% to 755,836 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    11/26/25 4:44:06 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    Chief Accounting Officer Lewis Michelle Renee covered exercise/tax liability with 16,777 shares, decreasing direct ownership by 5% to 326,591 units (SEC Form 4)

    4 - PACS Group, Inc. (0002001184) (Issuer)

    4/16/25 7:32:30 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Financials

    Live finance-specific insights

    View All

    PACS Group, Inc. Reports Third Quarter 2025 Results

    Completes Restatement of Previously Issued Financial Statements and Now Current with SEC Filing Obligations Audit Committee Completes Investigation Conference Call and Webcast Scheduled for Today, November 19, 2025, at 5:30 pm ET. PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the third quarter of 2025. The Company has completed the previously announced Restatement of its financial statements for the three months ended March 31, 2024, and for the three and six months ended on June 30, 2024 (the "Restatement"), and is current with its

    11/19/25 4:30:00 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Intends to Release Third Quarter 2025 Earnings and Submit SEC Filings on November 19, 2025

    PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, today announced that it intends to release its third quarter 2025 financial results and file its outstanding annual and quarterly filings through September 30, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on Wednesday, November 19, 2025. Management will host a call on Wednesday, November 19, 2025, at 5:30 p.m. ET to discuss the financial results and related information. The Company today filed a Form 12b-25, Notification of Late Filing, with the SEC related to its Quarterly Report on Form 10-Q for th

    11/17/25 9:05:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    PACS Group Provides Preliminary Third Quarter Operational Metrics

    Postpones Third Quarter 2024 Financial Results Conference Call PACS Group, Inc. (NYSE:PACS) ("PACS" or the "Company"), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable. "PACS Group operates in a highly regulated industry where compliance is of the utmost importance," said Jason Murray, PACS's Chief Executive Officer. "We believe recent third-party allegations are misleading. However, in line with our commitment to holding ourselves to a high standard – in how we serve our patients, op

    11/6/24 6:00:00 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    $PACS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:49 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 5:15:15 PM ET
    $PACS
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by PACS Group Inc.

    SC 13G - PACS Group, Inc. (0002001184) (Subject)

    11/14/24 11:37:42 AM ET
    $PACS
    Hospital/Nursing Management
    Health Care